Share on LinkedInShare on LinkedIn

ARTICLE · 03 OCTOBER 2018

(Surreptitious) Advertisement For A Medication

Global Advertising Lawyers Alliance (GALA)
Explore more from Global Advertising Lawyers Alliance (GALA)

The Dutch Advertising Code Committee (Reclame Code Commissie, RCC), received a complaint about communications in a brochure and on the website of the Stichting Bewegen Zonder Pijn (SBZP).

NetherlandsMedia, Telecoms, IT, Entertainment

The Dutch Advertising Code Committee (Reclame Code Commissie, RCC), received a complaint about communications in a brochure and on the website of the Stichting Bewegen Zonder Pijn (SBZP). The communications referred to a specific combination of ingredients. They seemed to be purely informative. But according to pharmaceutical industry association Neprofarm, they actually involved surreptitious advertising, partly originating from Synofit, a manufacturer of dietary supplements, for its product Synofit Premium. In a short film featuring a pharmacist, the reader is urged to use Google to search for a product that contains a combination of the ingredients in question. The consumer is then shown an AdWord advertisement for Synofit Premium. The SBZP asserts that this is not an ‘advertisement' but ‘information' about which individual ingredients soothe joint pain. Synofit, in turn, claims that it had nothing to do with either the SBZP or the communications.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from